The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...

Learn about the connection between hidden heart fat and inflammation and blood vessel problems. Find out why this fat can ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat substance abuse disorders, psychosis, infections, cancer, and dementia.

Insights from a study on GLP-1 receptor agonists reveal benefits for cardiometabolic health, with notable risks for ...

GLP-1 agents "have an intricate web of various effects," Al-Aly said in a press briefing. For example, the analysis showed ...

Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a recent study ...

Analysis of drugs such as Ozempic finds a lower health risk for 42 conditions but a higher rate of disorders such as arthritis ...

Peptidomics offered new diagnostic insights into the underlying processes of metabolic dyfunction-associated steatotic liver ...

Newer research highlights the shortcomings of using BMI alone to accurately diagnose obesity, especially for Indians.

Over 2 million people were included in new research to test these drugs against 175 different health outcomes.